A single blood test screening for more than 50 cancers substantially increases cancer detection when added to standard screenings, according to a study published in Nature Medicine by researchers at the Oregon Health & Science University Knight Cancer Institute. GRAIL’s Galleri test was assessed in the PATHFINDER 2 study, utilizing a machine-learning algorithm to analyze … Read more
According to researchers at Wuhan University, more than 3 billion people worldwide currently suffer from obesity, a figure forecasted to exceed 4 billion by 2035. To combat weight rebound and inflammation-suppressed fat browning linked to single-agent therapies, scientists developed an adipose-targeted composite microneedle patch named LRSG-SG@MN, which co-delivers semaglutide and rosiglitazone to modulate immune response … Read more
Open Dialogue, a person-centred mental health care model originating in Finland, significantly reduces psychiatric hospital admissions and improves patient quality of life, though it does not impact the time to first relapse, according to a randomised controlled trial led by University College London (UCL) researchers and published in The Lancet Psychiatry. Evaluating the ODDESSI Trial … Read more
Silver diamine fluoride (SDF) arrested between 50.2% and 57.5% of active cavitated dentin caries lesions in young children over an eight-month period, according to a phase 3 multisite clinical trial published in JAMA Pediatrics. The trial evaluated 830 generally healthy children aged 12 to 71 months with severe early childhood caries to inform US Food … Read more
Fractional dosing of COVID-19 vaccines can provide durable, long-lasting immunity comparable to full-dose boosters, according to a multi-year international study led by the Murdoch Children’s Research Institute (MCRI). Findings published across Nature Communications, Frontiers in Immunology, and the Journal of Infection suggest that reducing vaccine volume could lower costs and expand access to immunization in … Read more
The U.S. Food and Drug Administration approved zenocutuzumab as a second-line therapy for NRG1-positive cholangiocarcinoma on May 8. According to results from the eNRGy phase 2 clinical trial published in the Journal of Clinical Oncology, the drug more than doubled the median progression-free survival to 9.2 months, compared to the approximately four months typically seen … Read more
New Research Challenges Traditional Management of Immune-Tolerant Chronic Hepatitis B For patients diagnosed with chronic hepatitis B in the immune-tolerant (IT) phase, clinical management has historically been characterized by monitoring rather than active intervention. However, new findings published in the Journal of Clinical and Translational Hepatology suggest that a more proactive approach involving pegylated interferon … Read more
The Evolution of Stroke Prevention in Atrial Fibrillation: Moving Beyond Blood Thinners For decades, the gold standard for preventing strokes in patients with atrial fibrillation (AF) has been the steady use of oral anticoagulants. While effective, these medications come with a persistent and often frightening trade-off: the risk of major bleeding. For many, the fear … Read more
The Shift Toward Hyper-Localized Surveillance For years, wastewater surveillance was viewed through a wide-angle lens. Public health officials monitored municipal treatment plants to gauge the general prevalence of viruses like COVID-19 or influenza across an entire city. However, a paradigm shift is occurring: the move toward “hyper-localized” surveillance. Recent research led by the University of … Read more
The Shift Toward Oral Metabolic Health: A New Era for Seniors For years, the conversation around weight management in older adults has been cautious. The fear of muscle loss, the complexity of injectable medications, and a general lack of clinical data specifically targeting the 65+ demographic often left healthcare providers and patients hesitant. However, a … Read more